Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies

Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7
Technologies

New DICOM solutions can connect Q-Stress and Q-Tel cardiac rehab to healthcare
information systems

BOTHELL, Wash., March 30 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq:
CSCX), a global leader in advanced cardiac diagnosis, resuscitation,
rehabilitation, and informatics products, today added DICOM connectivity to
its Quinton Q-Stress cardiac stress testing system and Quinton Q-Tel cardiac
rehabilitation system.

"With DICOM and HL7 technologies, Cardiac Science is prepared to serve the
hospitals and physicians ready to take advantage of the Economic Stimulus
Bill," Director of Diagnostic Marketing for Cardiac Science Rene Mitchell
said. "This is another critical step in our path to be the diagnostic
connectivity leaders."

The Quinton Q-Stress can now connect to hospital information systems (HIS) and
electronic medical records (EMR) in the way that works best for each practice
or hospital. Among its benefits,
-- Less administration: Demographics, billing, and procedure codes can be
imported via bi-directional communication using DICOM or HL7.
-- Fewer errors and lost billing: Comprehensive tests can be exported to
minimize documentation errors.
-- Interoperability: Q-Stress can connect to virtually any EMR, HIS,
PACS,
and other healthcare systems including GE Muse.
-- Easy implementation: Little to no HIS customization is required.

-- Easy maintenance: There is little to no difficulty updating links as
an
HIS evolves.

First to offer DICOM connectivity to cardiac rehab segment

Cardiac Science is the first to offer DICOM connectivity to the cardiac
rehabilitation segment. With the addition of DICOM and HL7 technology, Q-Tel
now supports all the latest industry standards for connectivity.

"More cardiac rehab centers will connect their patient records to HIS systems.
Our DICOM and HL7 connectivity options will make the move much easier,"
Mitchell added.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced
diagnostic and therapeutic cardiology devices and systems, including automated
external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac
stress treadmill and systems, Holter monitoring systems, hospital
defibrillators, cardiac rehabilitation telemetry systems, and cardiology data
management systems (informatics) that connect with hospital information (HIS),
electronic medical record (EMR), and other information systems. The company
sells a variety of related products and consumables and provides a portfolio
of training, maintenance, and support services. Cardiac Science, the successor
to the cardiac businesses that established the trusted Burdick(R),
HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in
Bothell, Washington. With customers in more than 100 countries worldwide, the
company has operations in North America, Europe, and Asia. For information,
call 425.402.2000 or visit http://www.cardiacscience.com.

Forward Looking Statements

This press release contains forward-looking statements. The words "believe,"
"expect," "intend," "anticipate," variations of such words, and similar
expressions identify forward-looking statements, but their absence does not
mean that the statement is not forward-looking. Forward looking statements in
this press release include, but are not limited to, those relating to Cardiac
Science Corporation's expectations regarding revenue and profit potential
stemming from DICOM and HL7 capabilities. These are forward-looking statements
for purposes of the safe harbor provisions under the Private Securities
Litigation Reform Act of 1995. Actual results may vary significantly from the
results expressed or implied in such statements. Factors that could cause or
contribute to such varying results and other risks are more fully described in
Cardiac Science Corporation's Annual Report on Form 10-K for the year ended
December 31, 2008. Cardiac Science Corporation undertakes no duty or
obligation to update the information provided herein.

For more information,

Cardiac Science Contact: Investor Contact: Media Contact:
Mike Matysik Doug Sherk Christopher Gale
Cardiac Science Corporation Jenifer Kirtland EVC Group Inc.
Senior Vice President and CFO EVC Group Inc. 646.201.5431
425.402.2009 415.896.6820 203.570.4681
cgale@evcgroup.com

LOGO: http://www.cardiacscience.com/images/main_logo.gif
CSCX-G

SOURCE Cardiac Science

Mike Matysik, Senior Vice President and CFO of Cardiac Science Corporation,
+1-425-402-2009; or Doug Sherk or Jenifer Kirtland, Investor Contact,
+1-415-896-6820, or Christopher Gale, Media Contact, +1-646-201-5431, or
+1-203-570-4681, or cgale@evcgroup.com, all of EVC Group Inc.